Web Analytics

Susan B. Trujillo quoted in article "3 Takeaways From FDA's Drug Compounding Guidances"

Media Mention
Law360

Below is an excerpt:

Quarles & Brady LLP partner Susan B. Trujillo predicted that the FDA's position will draw fire from 503B outsourcing facilities that invested heavily in manufacturing upgrades but expected to maintain the capacity to operate more flexibly in certain areas as 503A pharmacies.

"I think this is going to have a big impact, especially in places that have already put an outsourcing facility at a location," Trujillo said.

Follow Quarles

Subscribe Media Contact
Back to Main Content

We use cookies to provide you with the best user experience on our website and to analyze statistics related to our website. To understand more about how we use cookies, or for instructions to change your preference and browser settings, please see our Privacy Notice. Please note that if you choose to reject cookies, doing so may impair some of our website's functionality.